US FDA Panel Recommends Approval of Nasal-Spray Depression Drug | Psychiatry & Behavioral Health Learning Network - Psych Congress Network

Submitted by Anonymous (not verified) on Tue, 02/12/2019 - 21:33

US FDA Panel Recommends Approval of Nasal-Spray Depression Drug | Psychiatry & Behavioral Health Learning Network  Psych Congress NetworkBy Saumya Joseph. An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended Johnson & Johnson's experimental nasal spray, ...